0.07
0.00%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Britannia Life Sciences
Its shares trade on Canadian Securities Exchange under the ticker BLAB.CN. It has been listed since 1 December 2017. In the fiscal year to 31 March 2026, it reported revenue of C$474,834 and net income of C$14.7m. At that date it held total assets of C$23.9m and shareholders' equity of C$20.7m.
Britannia Life Sciences, Inc. is a global product development platform. The company is headquartered in Toronto, Ontario. The company went IPO on 2017-12-01. The Company’s platform offers an integrated suite of services to assist companies along their product development journey. The firm provides product testing, safety assessment and compliance services to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally. The company is also engaged in the development and regulatory approval of topical and edible cannabis products, including preparation and support for novel food authorizations. Its services include product formulations, safety assessments, analytical and microbiological testing, global compliance, and consumer evaluations are offered to companies. The company serves consumer-packaged goods (CPG), cosmetics, household goods, nutraceutical industries, notable multinationals, retailers, brands, blue-chip and small and medium enterprise clients.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 1 Dec 2017
- Website
- riselifescience.com ↗
Leadership
Pay as last reported
- Mr. Greg TaylorIndependent Chairman of the BoardC$10,000
- Mr. Peter ShippenChief Executive Officer, Director, since 2021C$215,400
- Ms. Sarah ZilikChief Financial Officer, Company SecretaryC$132,000
- Mr. Mark Bowes CavanaghChief Technology OfficerC$172,000
- Mr. Scott SecordIndependent Director, since 2018C$10,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Global product development platform serving CPG, cosmetics, and nutraceutical industries.
- Integrated suite of services including product testing and safety assessment in the UK and globally.
- Topical and edible cannabis product development with regulatory approval support.
Weaknesses
- IPO listing date 1 December 2017 may indicate limited market presence.
- Headquartered in Toronto, Ontario, potentially limiting local market access.
- Services primarily focused on cosmetic and CPG industries without diversification.
Opportunities
- Expansion into novel food authorizations for cannabis products globally.
- Growing demand for safety assessments in the cosmetic industry.
- Increasing regulatory approvals for topical cannabis products in multiple countries.
Threats
- Regulatory challenges in the cannabis industry across different countries.
- Competition from established firms in the cosmetic testing sector.
- Economic downturns affecting consumer spending on CPG and cosmetics.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.